nodes	percent_of_prediction	percent_of_DWPC	metapath
Tirofiban—ITGB3—skin epidermis—psoriasis	0.11	0.349	CbGeAlD
Tirofiban—ITGA2B—endothelium—psoriasis	0.0915	0.29	CbGeAlD
Tirofiban—ITGB3—endothelium—psoriasis	0.08	0.253	CbGeAlD
Tirofiban—ITGB3—skin of body—psoriasis	0.0342	0.108	CbGeAlD
Tirofiban—Acute myocardial infarction—Acitretin—psoriasis	0.0294	0.0786	CcSEcCtD
Tirofiban—ITGA2B—Integrin family cell surface interactions—ITGAL—psoriasis	0.0248	0.0802	CbGpPWpGaD
Tirofiban—ITGB3—Integrin family cell surface interactions—ITGAL—psoriasis	0.0191	0.0617	CbGpPWpGaD
Tirofiban—ITGB3—Primary Focal Segmental Glomerulosclerosis FSGS—MKI67—psoriasis	0.0167	0.0541	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin cell surface interactions—ITGAL—psoriasis	0.0118	0.038	CbGpPWpGaD
Tirofiban—Cardiac tamponade—Methotrexate—psoriasis	0.0117	0.0312	CcSEcCtD
Tirofiban—ITGB3—MFAP5-mediated ovarian cancer cell motility and invasiveness—JUN—psoriasis	0.00966	0.0312	CbGpPWpGaD
Tirofiban—Swelling—Tazarotene—psoriasis	0.00923	0.0247	CcSEcCtD
Tirofiban—ITGB3—Integrin cell surface interactions—ITGAL—psoriasis	0.00908	0.0293	CbGpPWpGaD
Tirofiban—ITGB3—Osteopontin Signaling—NFKB1—psoriasis	0.00872	0.0282	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin-mediated Cell Adhesion—ITGAL—psoriasis	0.00845	0.0273	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—SERPINB8—psoriasis	0.00796	0.0257	CbGpPWpGaD
Tirofiban—Swelling—Fluocinonide—psoriasis	0.00706	0.0189	CcSEcCtD
Tirofiban—ITGB3—Osteopontin-mediated events—NFKBIA—psoriasis	0.00682	0.022	CbGpPWpGaD
Tirofiban—ITGB3—Cell surface interactions at the vascular wall—ITGAL—psoriasis	0.00656	0.0212	CbGpPWpGaD
Tirofiban—ITGB3—Integrin-mediated Cell Adhesion—ITGAL—psoriasis	0.00651	0.021	CbGpPWpGaD
Tirofiban—Hypercholesterolaemia—Calcitriol—psoriasis	0.00638	0.0171	CcSEcCtD
Tirofiban—ITGA2B—Signaling events mediated by PTP1B—LEP—psoriasis	0.00628	0.0203	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—SERPINB8—psoriasis	0.00613	0.0198	CbGpPWpGaD
Tirofiban—ITGB3—IL4-mediated signaling events—SOCS1—psoriasis	0.0057	0.0184	CbGpPWpGaD
Tirofiban—Hypercholesterolaemia—Acitretin—psoriasis	0.00568	0.0152	CcSEcCtD
Tirofiban—Haemoglobin—Tazarotene—psoriasis	0.00566	0.0151	CcSEcCtD
Tirofiban—Haemorrhage—Tazarotene—psoriasis	0.00564	0.0151	CcSEcCtD
Tirofiban—ITGB3—IL4-mediated signaling events—IL10—psoriasis	0.00511	0.0165	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—ITGAL—psoriasis	0.00506	0.0163	CbGpPWpGaD
Tirofiban—ITGB3—IL4-mediated signaling events—IL4—psoriasis	0.00497	0.016	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin cell surface interactions—ICAM1—psoriasis	0.00487	0.0157	CbGpPWpGaD
Tirofiban—ITGB3—Signaling events mediated by PTP1B—LEP—psoriasis	0.00484	0.0156	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling events mediated by PTP1B—TYK2—psoriasis	0.00479	0.0155	CbGpPWpGaD
Tirofiban—Haemoptysis—Mycophenolic acid—psoriasis	0.00477	0.0128	CcSEcCtD
Tirofiban—Pain—Calcipotriol—psoriasis	0.00464	0.0124	CcSEcCtD
Tirofiban—ITGB3—Osteopontin-mediated events—JUN—psoriasis	0.00452	0.0146	CbGpPWpGaD
Tirofiban—ITGB3—Osteopontin-mediated events—NFKB1—psoriasis	0.00435	0.014	CbGpPWpGaD
Tirofiban—ITGB3—Primary Focal Segmental Glomerulosclerosis FSGS—PCNA—psoriasis	0.00414	0.0133	CbGpPWpGaD
Tirofiban—Haematemesis—Mycophenolate mofetil—psoriasis	0.00401	0.0107	CcSEcCtD
Tirofiban—Oedema—Tazarotene—psoriasis	0.004	0.0107	CcSEcCtD
Tirofiban—Hypersensitivity—Calcipotriol—psoriasis	0.004	0.0107	CcSEcCtD
Tirofiban—ITGA2B—Beta3 integrin cell surface interactions—VEGFA—psoriasis	0.00395	0.0127	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—ITGAL—psoriasis	0.0039	0.0126	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—ITGAL—psoriasis	0.00389	0.0125	CbGpPWpGaD
Tirofiban—Haemoptysis—Mycophenolate mofetil—psoriasis	0.00377	0.0101	CcSEcCtD
Tirofiban—ITGB3—Integrin cell surface interactions—ICAM1—psoriasis	0.00376	0.0121	CbGpPWpGaD
Tirofiban—Hypercholesterolaemia—Mycophenolic acid—psoriasis	0.00373	0.00998	CcSEcCtD
Tirofiban—ITGB3—Signaling events mediated by PTP1B—TYK2—psoriasis	0.00369	0.0119	CbGpPWpGaD
Tirofiban—Pain—Tazarotene—psoriasis	0.00342	0.00915	CcSEcCtD
Tirofiban—ITGA2B—Signaling events mediated by PTP1B—STAT3—psoriasis	0.00336	0.0108	CbGpPWpGaD
Tirofiban—ITGB3—Monoamine Transport—TNF—psoriasis	0.0033	0.0107	CbGpPWpGaD
Tirofiban—Anaphylactic shock—Beclomethasone—psoriasis	0.00309	0.00826	CcSEcCtD
Tirofiban—Haemoglobin—Calcitriol—psoriasis	0.00305	0.00814	CcSEcCtD
Tirofiban—ITGB3—Beta3 integrin cell surface interactions—VEGFA—psoriasis	0.00304	0.00981	CbGpPWpGaD
Tirofiban—Haemorrhage—Calcitriol—psoriasis	0.00303	0.0081	CcSEcCtD
Tirofiban—ITGB3—Extracellular matrix organization—ITGAL—psoriasis	0.003	0.00967	CbGpPWpGaD
Tirofiban—Hypercholesterolaemia—Mycophenolate mofetil—psoriasis	0.00295	0.00788	CcSEcCtD
Tirofiban—Swelling—Mycophenolic acid—psoriasis	0.00291	0.00777	CcSEcCtD
Tirofiban—Pain—Clobetasol propionate—psoriasis	0.0029	0.00776	CcSEcCtD
Tirofiban—ITGA2B—Hematopoietic Stem Cell Differentiation—IL6—psoriasis	0.00289	0.00933	CbGpPWpGaD
Tirofiban—Haematuria—Acitretin—psoriasis	0.00286	0.00766	CcSEcCtD
Tirofiban—Haemoglobin—Acitretin—psoriasis	0.00271	0.00725	CcSEcCtD
Tirofiban—Haemorrhage—Acitretin—psoriasis	0.0027	0.00721	CcSEcCtD
Tirofiban—Pain—Beclomethasone—psoriasis	0.00264	0.00706	CcSEcCtD
Tirofiban—Pain—Fluocinonide—psoriasis	0.00262	0.007	CcSEcCtD
Tirofiban—ITGB3—Signaling events mediated by PTP1B—STAT3—psoriasis	0.00259	0.00835	CbGpPWpGaD
Tirofiban—Hypersensitivity—Clobetasol propionate—psoriasis	0.0025	0.00668	CcSEcCtD
Tirofiban—Urticaria—Beclomethasone—psoriasis	0.00246	0.00656	CcSEcCtD
Tirofiban—Chills—Acitretin—psoriasis	0.00242	0.00647	CcSEcCtD
Tirofiban—Oedema—Methoxsalen—psoriasis	0.00242	0.00646	CcSEcCtD
Tirofiban—ITGA2B—Platelet degranulation—VEGFA—psoriasis	0.0024	0.00775	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—ITGAL—psoriasis	0.00231	0.00746	CbGpPWpGaD
Tirofiban—ITGA2B—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	0.00229	0.00738	CbGpPWpGaD
Tirofiban—Hypertension—Calcitriol—psoriasis	0.00228	0.00609	CcSEcCtD
Tirofiban—Haematemesis—Methotrexate—psoriasis	0.00227	0.00607	CcSEcCtD
Tirofiban—Hypersensitivity—Fluocinonide—psoriasis	0.00226	0.00603	CcSEcCtD
Tirofiban—ITGB3—Integrins in angiogenesis—VEGFA—psoriasis	0.00224	0.00723	CbGpPWpGaD
Tirofiban—ITGB3—Hematopoietic Stem Cell Differentiation—IL6—psoriasis	0.00223	0.00719	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—CARM1—psoriasis	0.00217	0.007	CbGpPWpGaD
Tirofiban—Anaphylactic shock—Calcitriol—psoriasis	0.00215	0.00576	CcSEcCtD
Tirofiban—Haemoglobin—Hydroxyurea—psoriasis	0.00213	0.00569	CcSEcCtD
Tirofiban—Headache—Clobetasol propionate—psoriasis	0.00213	0.00568	CcSEcCtD
Tirofiban—Haemorrhage—Hydroxyurea—psoriasis	0.00212	0.00566	CcSEcCtD
Tirofiban—ITGB3—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—psoriasis	0.00211	0.0068	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—TYK2—psoriasis	0.00207	0.00669	CbGpPWpGaD
Tirofiban—Dizziness—Beclomethasone—psoriasis	0.00204	0.00546	CcSEcCtD
Tirofiban—Dizziness—Fluocinonide—psoriasis	0.00202	0.00541	CcSEcCtD
Tirofiban—Hypercholesterolaemia—Prednisone—psoriasis	0.002	0.00534	CcSEcCtD
Tirofiban—ITGB3—Signaling by VEGF—TYK2—psoriasis	0.00196	0.00632	CbGpPWpGaD
Tirofiban—Headache—Beclomethasone—psoriasis	0.00194	0.00517	CcSEcCtD
Tirofiban—Urticaria—Methoxsalen—psoriasis	0.00192	0.00513	CcSEcCtD
Tirofiban—Headache—Fluocinonide—psoriasis	0.00192	0.00513	CcSEcCtD
Tirofiban—Oedema—Acitretin—psoriasis	0.00192	0.00512	CcSEcCtD
Tirofiban—Oedema—Fluocinolone Acetonide—psoriasis	0.00191	0.00511	CcSEcCtD
Tirofiban—Body temperature increased—Methoxsalen—psoriasis	0.00191	0.00511	CcSEcCtD
Tirofiban—Chills—Hydroxyurea—psoriasis	0.0019	0.00508	CcSEcCtD
Tirofiban—Sweating—Mycophenolic acid—psoriasis	0.00189	0.00506	CcSEcCtD
Tirofiban—Haematuria—Mycophenolic acid—psoriasis	0.00188	0.00503	CcSEcCtD
Tirofiban—Hyperhidrosis—Acitretin—psoriasis	0.00185	0.00495	CcSEcCtD
Tirofiban—ITGB3—Platelet degranulation—VEGFA—psoriasis	0.00185	0.00597	CbGpPWpGaD
Tirofiban—Pain—Calcitriol—psoriasis	0.00184	0.00492	CcSEcCtD
Tirofiban—Nausea—Beclomethasone—psoriasis	0.00184	0.00491	CcSEcCtD
Tirofiban—Bradycardia—Mycophenolic acid—psoriasis	0.00181	0.00483	CcSEcCtD
Tirofiban—Haemoglobin—Mycophenolic acid—psoriasis	0.00178	0.00476	CcSEcCtD
Tirofiban—Hypersensitivity—Methoxsalen—psoriasis	0.00178	0.00476	CcSEcCtD
Tirofiban—ITGB3—Hemostasis—ITGAL—psoriasis	0.00178	0.00574	CbGpPWpGaD
Tirofiban—Haemorrhage—Mycophenolic acid—psoriasis	0.00177	0.00474	CcSEcCtD
Tirofiban—ITGB3—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	0.00176	0.00569	CbGpPWpGaD
Tirofiban—Urticaria—Calcitriol—psoriasis	0.00171	0.00457	CcSEcCtD
Tirofiban—Body temperature increased—Calcitriol—psoriasis	0.0017	0.00455	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—CARM1—psoriasis	0.00167	0.0054	CbGpPWpGaD
Tirofiban—Pain—Acitretin—psoriasis	0.00164	0.00438	CcSEcCtD
Tirofiban—Pain—Fluocinolone Acetonide—psoriasis	0.00163	0.00437	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—HCAR2—psoriasis	0.00163	0.00527	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—ICAM1—psoriasis	0.00161	0.00519	CbGpPWpGaD
Tirofiban—Dizziness—Methoxsalen—psoriasis	0.0016	0.00427	CcSEcCtD
Tirofiban—Chills—Mycophenolic acid—psoriasis	0.00159	0.00425	CcSEcCtD
Tirofiban—Hypersensitivity—Calcitriol—psoriasis	0.00159	0.00424	CcSEcCtD
Tirofiban—Myocardial infarction—Cyclosporine—psoriasis	0.00157	0.00419	CcSEcCtD
Tirofiban—Myocardial infarction—Mycophenolate mofetil—psoriasis	0.00153	0.00408	CcSEcCtD
Tirofiban—Haematuria—Cyclosporine—psoriasis	0.00152	0.00407	CcSEcCtD
Tirofiban—Urticaria—Acitretin—psoriasis	0.00152	0.00407	CcSEcCtD
Tirofiban—Body temperature increased—Acitretin—psoriasis	0.00151	0.00405	CcSEcCtD
Tirofiban—Headache—Methoxsalen—psoriasis	0.00151	0.00405	CcSEcCtD
Tirofiban—Body temperature increased—Fluocinolone Acetonide—psoriasis	0.00151	0.00404	CcSEcCtD
Tirofiban—Oedema—Hydroxyurea—psoriasis	0.0015	0.00402	CcSEcCtD
Tirofiban—Sweating—Mycophenolate mofetil—psoriasis	0.00149	0.004	CcSEcCtD
Tirofiban—Haematuria—Mycophenolate mofetil—psoriasis	0.00149	0.00397	CcSEcCtD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—JUN—psoriasis	0.00148	0.00478	CbGpPWpGaD
Tirofiban—Thrombocytopenia—Hydroxyurea—psoriasis	0.00147	0.00394	CcSEcCtD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—VEGFA—psoriasis	0.00147	0.00473	CbGpPWpGaD
Tirofiban—Haemoglobin—Cyclosporine—psoriasis	0.00144	0.00385	CcSEcCtD
Tirofiban—Nausea—Methoxsalen—psoriasis	0.00144	0.00384	CcSEcCtD
Tirofiban—Haemorrhage—Cyclosporine—psoriasis	0.00143	0.00383	CcSEcCtD
Tirofiban—Myocardial infarction—Prednisolone—psoriasis	0.00143	0.00381	CcSEcCtD
Tirofiban—Bradycardia—Mycophenolate mofetil—psoriasis	0.00142	0.00381	CcSEcCtD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—JUN—psoriasis	0.00142	0.00458	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TAGAP—psoriasis	0.00142	0.00457	CbGpPWpGaD
Tirofiban—Hypersensitivity—Acitretin—psoriasis	0.00141	0.00377	CcSEcCtD
Tirofiban—Hypersensitivity—Fluocinolone Acetonide—psoriasis	0.00141	0.00376	CcSEcCtD
Tirofiban—Haemoglobin—Mycophenolate mofetil—psoriasis	0.00141	0.00376	CcSEcCtD
Tirofiban—Haemorrhage—Mycophenolate mofetil—psoriasis	0.0014	0.00374	CcSEcCtD
Tirofiban—Myocardial infarction—Hydrocortisone—psoriasis	0.00139	0.00372	CcSEcCtD
Tirofiban—ITGB3—Signaling by VEGF—VEGFA—psoriasis	0.00138	0.00447	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—JUN—psoriasis	0.00138	0.00444	CbGpPWpGaD
Tirofiban—Headache—Calcitriol—psoriasis	0.00135	0.00361	CcSEcCtD
Tirofiban—Hypertension—Mycophenolic acid—psoriasis	0.00133	0.00356	CcSEcCtD
Tirofiban—Bradycardia—Prednisolone—psoriasis	0.00133	0.00355	CcSEcCtD
Tirofiban—Haemoglobin—Prednisolone—psoriasis	0.00131	0.00351	CcSEcCtD
Tirofiban—Myocardial infarction—Triamcinolone—psoriasis	0.00131	0.0035	CcSEcCtD
Tirofiban—Haemorrhage—Prednisolone—psoriasis	0.00131	0.00349	CcSEcCtD
Tirofiban—Bradycardia—Hydrocortisone—psoriasis	0.0013	0.00347	CcSEcCtD
Tirofiban—Chills—Cyclosporine—psoriasis	0.00129	0.00344	CcSEcCtD
Tirofiban—Pain—Hydroxyurea—psoriasis	0.00129	0.00344	CcSEcCtD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—STAT3—psoriasis	0.00128	0.00414	CbGpPWpGaD
Tirofiban—Haemoglobin—Hydrocortisone—psoriasis	0.00128	0.00343	CcSEcCtD
Tirofiban—Nausea—Calcitriol—psoriasis	0.00128	0.00342	CcSEcCtD
Tirofiban—Haemorrhage—Hydrocortisone—psoriasis	0.00128	0.00341	CcSEcCtD
Tirofiban—Dizziness—Acitretin—psoriasis	0.00127	0.00339	CcSEcCtD
Tirofiban—Dizziness—Fluocinolone Acetonide—psoriasis	0.00126	0.00338	CcSEcCtD
Tirofiban—Oedema—Mycophenolic acid—psoriasis	0.00126	0.00337	CcSEcCtD
Tirofiban—ITGB3—Signaling Pathways—HCAR2—psoriasis	0.00126	0.00406	CbGpPWpGaD
Tirofiban—Chills—Mycophenolate mofetil—psoriasis	0.00126	0.00336	CcSEcCtD
Tirofiban—ITGB3—Extracellular matrix organization—ICAM1—psoriasis	0.00124	0.004	CbGpPWpGaD
Tirofiban—Thrombocytopenia—Mycophenolic acid—psoriasis	0.00123	0.0033	CcSEcCtD
Tirofiban—Bradycardia—Triamcinolone—psoriasis	0.00122	0.00327	CcSEcCtD
Tirofiban—Hyperhidrosis—Mycophenolic acid—psoriasis	0.00122	0.00326	CcSEcCtD
Tirofiban—Haemoglobin—Triamcinolone—psoriasis	0.00121	0.00323	CcSEcCtD
Tirofiban—ITGA2B—Focal Adhesion—VEGFA—psoriasis	0.0012	0.00388	CbGpPWpGaD
Tirofiban—Haemorrhage—Triamcinolone—psoriasis	0.0012	0.00321	CcSEcCtD
Tirofiban—Headache—Acitretin—psoriasis	0.0012	0.00321	CcSEcCtD
Tirofiban—Headache—Fluocinolone Acetonide—psoriasis	0.0012	0.0032	CcSEcCtD
Tirofiban—Myocardial infarction—Betamethasone—psoriasis	0.00119	0.00318	CcSEcCtD
Tirofiban—Myocardial infarction—Dexamethasone—psoriasis	0.00119	0.00318	CcSEcCtD
Tirofiban—Body temperature increased—Hydroxyurea—psoriasis	0.00119	0.00318	CcSEcCtD
Tirofiban—Nausea—Acitretin—psoriasis	0.00114	0.00304	CcSEcCtD
Tirofiban—Nausea—Fluocinolone Acetonide—psoriasis	0.00114	0.00303	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—TYK2—psoriasis	0.00111	0.00358	CbGpPWpGaD
Tirofiban—Bradycardia—Betamethasone—psoriasis	0.00111	0.00296	CcSEcCtD
Tirofiban—Bradycardia—Dexamethasone—psoriasis	0.00111	0.00296	CcSEcCtD
Tirofiban—Hypersensitivity—Hydroxyurea—psoriasis	0.00111	0.00296	CcSEcCtD
Tirofiban—Haemoglobin—Betamethasone—psoriasis	0.0011	0.00293	CcSEcCtD
Tirofiban—Haemoglobin—Dexamethasone—psoriasis	0.0011	0.00293	CcSEcCtD
Tirofiban—ITGB3—Signaling Pathways—TAGAP—psoriasis	0.00109	0.00352	CbGpPWpGaD
Tirofiban—Haemorrhage—Betamethasone—psoriasis	0.00109	0.00291	CcSEcCtD
Tirofiban—Haemorrhage—Dexamethasone—psoriasis	0.00109	0.00291	CcSEcCtD
Tirofiban—Hypertension—Cyclosporine—psoriasis	0.00108	0.00288	CcSEcCtD
Tirofiban—Pain—Mycophenolic acid—psoriasis	0.00108	0.00288	CcSEcCtD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—VEGFA—psoriasis	0.00107	0.00344	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—JUN—psoriasis	0.00106	0.00342	CbGpPWpGaD
Tirofiban—Hypertension—Mycophenolate mofetil—psoriasis	0.00105	0.00281	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—LEP—psoriasis	0.00104	0.00335	CbGpPWpGaD
Tirofiban—Myocardial infarction—Prednisone—psoriasis	0.00104	0.00277	CcSEcCtD
Tirofiban—Anaphylactic shock—Cyclosporine—psoriasis	0.00102	0.00272	CcSEcCtD
Tirofiban—Oedema—Cyclosporine—psoriasis	0.00102	0.00272	CcSEcCtD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—IL6—psoriasis	0.00101	0.00327	CbGpPWpGaD
Tirofiban—Thrombocytopenia—Cyclosporine—psoriasis	0.000998	0.00267	CcSEcCtD
Tirofiban—Body temperature increased—Mycophenolic acid—psoriasis	0.000996	0.00266	CcSEcCtD
Tirofiban—Dizziness—Hydroxyurea—psoriasis	0.000995	0.00266	CcSEcCtD
Tirofiban—Anaphylactic shock—Mycophenolate mofetil—psoriasis	0.000994	0.00266	CcSEcCtD
Tirofiban—Oedema—Mycophenolate mofetil—psoriasis	0.000994	0.00266	CcSEcCtD
Tirofiban—Hyperhidrosis—Cyclosporine—psoriasis	0.000986	0.00263	CcSEcCtD
Tirofiban—Hypertension—Prednisolone—psoriasis	0.000981	0.00262	CcSEcCtD
Tirofiban—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.000974	0.0026	CcSEcCtD
Tirofiban—Bradycardia—Prednisone—psoriasis	0.000966	0.00258	CcSEcCtD
Tirofiban—Hyperhidrosis—Mycophenolate mofetil—psoriasis	0.000961	0.00257	CcSEcCtD
Tirofiban—Hypertension—Hydrocortisone—psoriasis	0.000958	0.00256	CcSEcCtD
Tirofiban—ITGB3—Signaling by VEGF—IL6—psoriasis	0.000957	0.00309	CbGpPWpGaD
Tirofiban—Haemoglobin—Prednisone—psoriasis	0.000954	0.00255	CcSEcCtD
Tirofiban—Haemorrhage—Prednisone—psoriasis	0.000949	0.00254	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—NOS2—psoriasis	0.000948	0.00306	CbGpPWpGaD
Tirofiban—Headache—Hydroxyurea—psoriasis	0.000943	0.00252	CcSEcCtD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—TP53—psoriasis	0.000936	0.00302	CbGpPWpGaD
Tirofiban—Anaphylactic shock—Prednisolone—psoriasis	0.000928	0.00248	CcSEcCtD
Tirofiban—Oedema—Prednisolone—psoriasis	0.000928	0.00248	CcSEcCtD
Tirofiban—ITGB3—Focal Adhesion—VEGFA—psoriasis	0.000926	0.00299	CbGpPWpGaD
Tirofiban—Anaphylactic shock—Hydrocortisone—psoriasis	0.000906	0.00242	CcSEcCtD
Tirofiban—Oedema—Hydrocortisone—psoriasis	0.000906	0.00242	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—PPARG—psoriasis	0.000903	0.00292	CbGpPWpGaD
Tirofiban—Hypertension—Triamcinolone—psoriasis	0.000902	0.00241	CcSEcCtD
Tirofiban—Hyperhidrosis—Prednisolone—psoriasis	0.000897	0.0024	CcSEcCtD
Tirofiban—Nausea—Hydroxyurea—psoriasis	0.000894	0.00239	CcSEcCtD
Tirofiban—Hyperhidrosis—Hydrocortisone—psoriasis	0.000876	0.00234	CcSEcCtD
Tirofiban—Pain—Cyclosporine—psoriasis	0.000872	0.00233	CcSEcCtD
Tirofiban—ITGB3—Axon guidance—TYK2—psoriasis	0.000854	0.00276	CbGpPWpGaD
Tirofiban—Anaphylactic shock—Triamcinolone—psoriasis	0.000853	0.00228	CcSEcCtD
Tirofiban—Oedema—Triamcinolone—psoriasis	0.000853	0.00228	CcSEcCtD
Tirofiban—Pain—Mycophenolate mofetil—psoriasis	0.00085	0.00227	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—CCL20—psoriasis	0.000849	0.00274	CbGpPWpGaD
Tirofiban—Sweating—Methotrexate—psoriasis	0.000847	0.00226	CcSEcCtD
Tirofiban—Haematuria—Methotrexate—psoriasis	0.000842	0.00225	CcSEcCtD
Tirofiban—Dizziness—Mycophenolic acid—psoriasis	0.000833	0.00223	CcSEcCtD
Tirofiban—Hyperhidrosis—Triamcinolone—psoriasis	0.000825	0.0022	CcSEcCtD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—VEGFA—psoriasis	0.000821	0.00265	CbGpPWpGaD
Tirofiban—Hypertension—Betamethasone—psoriasis	0.000819	0.00219	CcSEcCtD
Tirofiban—Hypertension—Dexamethasone—psoriasis	0.000819	0.00219	CcSEcCtD
Tirofiban—Urticaria—Cyclosporine—psoriasis	0.00081	0.00216	CcSEcCtD
Tirofiban—Body temperature increased—Cyclosporine—psoriasis	0.000806	0.00215	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—LEP—psoriasis	0.000799	0.00258	CbGpPWpGaD
Tirofiban—Haemoglobin—Methotrexate—psoriasis	0.000797	0.00213	CcSEcCtD
Tirofiban—Pain—Prednisolone—psoriasis	0.000793	0.00212	CcSEcCtD
Tirofiban—Haemorrhage—Methotrexate—psoriasis	0.000793	0.00212	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—TYK2—psoriasis	0.000792	0.00255	CbGpPWpGaD
Tirofiban—Urticaria—Mycophenolate mofetil—psoriasis	0.00079	0.00211	CcSEcCtD
Tirofiban—Headache—Mycophenolic acid—psoriasis	0.000789	0.00211	CcSEcCtD
Tirofiban—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000786	0.0021	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—VEGFA—psoriasis	0.000784	0.00253	CbGpPWpGaD
Tirofiban—Pain—Hydrocortisone—psoriasis	0.000775	0.00207	CcSEcCtD
Tirofiban—Anaphylactic shock—Dexamethasone—psoriasis	0.000774	0.00207	CcSEcCtD
Tirofiban—Oedema—Betamethasone—psoriasis	0.000774	0.00207	CcSEcCtD
Tirofiban—Oedema—Dexamethasone—psoriasis	0.000774	0.00207	CcSEcCtD
Tirofiban—Anaphylactic shock—Betamethasone—psoriasis	0.000774	0.00207	CcSEcCtD
Tirofiban—Thrombocytopenia—Dexamethasone—psoriasis	0.000758	0.00203	CcSEcCtD
Tirofiban—Thrombocytopenia—Betamethasone—psoriasis	0.000758	0.00203	CcSEcCtD
Tirofiban—Hypersensitivity—Cyclosporine—psoriasis	0.000751	0.00201	CcSEcCtD
Tirofiban—Nausea—Mycophenolic acid—psoriasis	0.000748	0.002	CcSEcCtD
Tirofiban—Hyperhidrosis—Dexamethasone—psoriasis	0.000748	0.002	CcSEcCtD
Tirofiban—Hyperhidrosis—Betamethasone—psoriasis	0.000748	0.002	CcSEcCtD
Tirofiban—Urticaria—Prednisolone—psoriasis	0.000737	0.00197	CcSEcCtD
Tirofiban—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000733	0.00196	CcSEcCtD
Tirofiban—ITGB3—Hemostasis—NOS2—psoriasis	0.00073	0.00236	CbGpPWpGaD
Tirofiban—Pain—Triamcinolone—psoriasis	0.00073	0.00195	CcSEcCtD
Tirofiban—Urticaria—Hydrocortisone—psoriasis	0.00072	0.00192	CcSEcCtD
Tirofiban—Body temperature increased—Hydrocortisone—psoriasis	0.000716	0.00191	CcSEcCtD
Tirofiban—Hypertension—Prednisone—psoriasis	0.000713	0.00191	CcSEcCtD
Tirofiban—Chills—Methotrexate—psoriasis	0.000711	0.0019	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—PPARG—psoriasis	0.000696	0.00225	CbGpPWpGaD
Tirofiban—Hypersensitivity—Prednisolone—psoriasis	0.000683	0.00183	CcSEcCtD
Tirofiban—Urticaria—Triamcinolone—psoriasis	0.000678	0.00181	CcSEcCtD
Tirofiban—Body temperature increased—Triamcinolone—psoriasis	0.000674	0.0018	CcSEcCtD
Tirofiban—Dizziness—Cyclosporine—psoriasis	0.000674	0.0018	CcSEcCtD
Tirofiban—Oedema—Prednisone—psoriasis	0.000674	0.0018	CcSEcCtD
Tirofiban—Anaphylactic shock—Prednisone—psoriasis	0.000674	0.0018	CcSEcCtD
Tirofiban—Hypersensitivity—Hydrocortisone—psoriasis	0.000667	0.00178	CcSEcCtD
Tirofiban—Pain—Dexamethasone—psoriasis	0.000662	0.00177	CcSEcCtD
Tirofiban—Pain—Betamethasone—psoriasis	0.000662	0.00177	CcSEcCtD
Tirofiban—Dizziness—Mycophenolate mofetil—psoriasis	0.000658	0.00176	CcSEcCtD
Tirofiban—ITGB3—Signaling Pathways—CCL20—psoriasis	0.000654	0.00211	CbGpPWpGaD
Tirofiban—Hyperhidrosis—Prednisone—psoriasis	0.000652	0.00174	CcSEcCtD
Tirofiban—Headache—Cyclosporine—psoriasis	0.000639	0.00171	CcSEcCtD
Tirofiban—Hypersensitivity—Triamcinolone—psoriasis	0.000629	0.00168	CcSEcCtD
Tirofiban—Headache—Mycophenolate mofetil—psoriasis	0.000623	0.00166	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—NFKB1—psoriasis	0.000617	0.00199	CbGpPWpGaD
Tirofiban—Urticaria—Dexamethasone—psoriasis	0.000615	0.00164	CcSEcCtD
Tirofiban—Urticaria—Betamethasone—psoriasis	0.000615	0.00164	CcSEcCtD
Tirofiban—Dizziness—Prednisolone—psoriasis	0.000613	0.00164	CcSEcCtD
Tirofiban—Body temperature increased—Betamethasone—psoriasis	0.000612	0.00164	CcSEcCtD
Tirofiban—Body temperature increased—Dexamethasone—psoriasis	0.000612	0.00164	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—TYK2—psoriasis	0.00061	0.00197	CbGpPWpGaD
Tirofiban—Nausea—Cyclosporine—psoriasis	0.000606	0.00162	CcSEcCtD
Tirofiban—ITGB3—Axon guidance—VEGFA—psoriasis	0.000604	0.00195	CbGpPWpGaD
Tirofiban—Dizziness—Hydrocortisone—psoriasis	0.000599	0.0016	CcSEcCtD
Tirofiban—Nausea—Mycophenolate mofetil—psoriasis	0.000591	0.00158	CcSEcCtD
Tirofiban—Headache—Prednisolone—psoriasis	0.000581	0.00155	CcSEcCtD
Tirofiban—Headache—Hydrocortisone—psoriasis	0.000568	0.00152	CcSEcCtD
Tirofiban—Dizziness—Triamcinolone—psoriasis	0.000564	0.00151	CcSEcCtD
Tirofiban—Anaphylactic shock—Methotrexate—psoriasis	0.000563	0.00151	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—VEGFA—psoriasis	0.00056	0.00181	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—STAT3—psoriasis	0.000554	0.00179	CbGpPWpGaD
Tirofiban—Thrombocytopenia—Methotrexate—psoriasis	0.000552	0.00147	CcSEcCtD
Tirofiban—Nausea—Prednisolone—psoriasis	0.000551	0.00147	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—VEGFA—psoriasis	0.000549	0.00177	CbGpPWpGaD
Tirofiban—Hyperhidrosis—Methotrexate—psoriasis	0.000545	0.00146	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—IL6—psoriasis	0.000542	0.00175	CbGpPWpGaD
Tirofiban—Nausea—Hydrocortisone—psoriasis	0.000538	0.00144	CcSEcCtD
Tirofiban—Urticaria—Prednisone—psoriasis	0.000536	0.00143	CcSEcCtD
Tirofiban—Headache—Triamcinolone—psoriasis	0.000534	0.00143	CcSEcCtD
Tirofiban—Body temperature increased—Prednisone—psoriasis	0.000533	0.00142	CcSEcCtD
Tirofiban—Dizziness—Betamethasone—psoriasis	0.000512	0.00137	CcSEcCtD
Tirofiban—Dizziness—Dexamethasone—psoriasis	0.000512	0.00137	CcSEcCtD
Tirofiban—Nausea—Triamcinolone—psoriasis	0.000507	0.00135	CcSEcCtD
Tirofiban—Hypersensitivity—Prednisone—psoriasis	0.000497	0.00133	CcSEcCtD
Tirofiban—Headache—Betamethasone—psoriasis	0.000485	0.0013	CcSEcCtD
Tirofiban—Headache—Dexamethasone—psoriasis	0.000485	0.0013	CcSEcCtD
Tirofiban—Pain—Methotrexate—psoriasis	0.000482	0.00129	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—TNF—psoriasis	0.00048	0.00155	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—NFKB1—psoriasis	0.000475	0.00153	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—SOCS1—psoriasis	0.000467	0.00151	CbGpPWpGaD
Tirofiban—Nausea—Dexamethasone—psoriasis	0.00046	0.00123	CcSEcCtD
Tirofiban—Nausea—Betamethasone—psoriasis	0.00046	0.00123	CcSEcCtD
Tirofiban—Urticaria—Methotrexate—psoriasis	0.000448	0.0012	CcSEcCtD
Tirofiban—Dizziness—Prednisone—psoriasis	0.000446	0.00119	CcSEcCtD
Tirofiban—Body temperature increased—Methotrexate—psoriasis	0.000445	0.00119	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—VEGFA—psoriasis	0.000431	0.00139	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—STAT3—psoriasis	0.000427	0.00138	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—VEGFA—psoriasis	0.000423	0.00137	CbGpPWpGaD
Tirofiban—Headache—Prednisone—psoriasis	0.000422	0.00113	CcSEcCtD
Tirofiban—ITGB3—Axon guidance—IL6—psoriasis	0.000418	0.00135	CbGpPWpGaD
Tirofiban—Hypersensitivity—Methotrexate—psoriasis	0.000415	0.00111	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—TP53—psoriasis	0.000415	0.00134	CbGpPWpGaD
Tirofiban—Nausea—Prednisone—psoriasis	0.0004	0.00107	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—IL6—psoriasis	0.000387	0.00125	CbGpPWpGaD
Tirofiban—Dizziness—Methotrexate—psoriasis	0.000373	0.000996	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—TNF—psoriasis	0.00037	0.00119	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—SOCS1—psoriasis	0.00036	0.00116	CbGpPWpGaD
Tirofiban—Headache—Methotrexate—psoriasis	0.000353	0.000943	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—LEP—psoriasis	0.000345	0.00111	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—APOE—psoriasis	0.000345	0.00111	CbGpPWpGaD
Tirofiban—Nausea—Methotrexate—psoriasis	0.000335	0.000894	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—NFKBIA—psoriasis	0.000321	0.00104	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—TP53—psoriasis	0.00032	0.00103	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—IL6—psoriasis	0.000298	0.000963	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—LEP—psoriasis	0.000266	0.000858	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—APOE—psoriasis	0.000266	0.000858	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TYK2—psoriasis	0.000263	0.00085	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—NFKBIA—psoriasis	0.000248	0.000799	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CXCL8—psoriasis	0.000229	0.00074	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—JUN—psoriasis	0.000213	0.000688	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—NFKB1—psoriasis	0.000205	0.000662	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TYK2—psoriasis	0.000203	0.000655	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—VEGFA—psoriasis	0.000186	0.000601	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—STAT3—psoriasis	0.000184	0.000595	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CXCL8—psoriasis	0.000177	0.00057	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—JUN—psoriasis	0.000164	0.00053	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—NFKB1—psoriasis	0.000158	0.00051	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—VEGFA—psoriasis	0.000143	0.000463	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—STAT3—psoriasis	0.000142	0.000458	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TP53—psoriasis	0.000141	0.000454	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IL6—psoriasis	0.000129	0.000416	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TP53—psoriasis	0.000108	0.00035	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IL6—psoriasis	9.92e-05	0.00032	CbGpPWpGaD
